» Articles » PMID: 38596498

Optimizing Nutrition in Hepatic Cirrhosis: A Comprehensive Assessment and Care Approach

Overview
Specialty Gastroenterology
Date 2024 Apr 10
PMID 38596498
Authors
Affiliations
Soon will be listed here.
Abstract

Cirrhosis is considered a growing cause of morbidity and mortality, which represents a significant public health problem. Currently, there is no effective treatment to reverse cirrhosis. Treatment primarily centers on addressing the underlying liver condition, monitoring, and managing portal hypertension-related complications, and evaluating the potential for liver transplantation in cases of decompensated cirrhosis, marked by rapid progression and the emergence of complications like variceal bleeding, hepatic encephalopathy, ascites, malnutrition, and more. Malnutrition, a prevalent complication across all disease stages, is often underdiagnosed in cirrhosis due to the complexities of nutritional assessment in patients with fluid retention and/or obesity, despite its crucial impact on prognosis. Increasing emphasis has been placed on the collaboration of nutritionists within hepatology and Liver transplant teams to deliver comprehensive care, a practice that has shown to improve outcomes. This review covers appropriate screening and assessment methods for evaluating the nutritional status of this population, diagnostic approaches for malnutrition, and context-specific nutrition treatments. It also discusses evidence-based recommendations for supplementation and physical exercise, both essential elements of the standard care provided to cirrhotic patients.

Citing Articles

Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.

Liu P, Liang W, Huang R, Chen X, Zou D, Kurihara H Front Pharmacol. 2024; 15:1399598.

PMID: 39108760 PMC: 11300221. DOI: 10.3389/fphar.2024.1399598.

References
1.
Tome S, Lucey M . Review article: current management of alcoholic liver disease. Aliment Pharmacol Ther. 2004; 19(7):707-14. DOI: 10.1111/j.1365-2036.2004.01881.x. View

2.
Parlesak A, Schafer C, Schutz T, Bode J, Bode C . Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000; 32(5):742-7. DOI: 10.1016/s0168-8278(00)80242-1. View

3.
Bajaj J, OLeary J, Tandon P, Wong F, Garcia-Tsao G, Kamath P . Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures. Clin Gastroenterol Hepatol. 2016; 15(4):565-574.e4. DOI: 10.1016/j.cgh.2016.09.157. View

4.
Kumar R, Marrapu S . Dietary salt in liver cirrhosis: With a pinch of salt!. World J Hepatol. 2023; 15(10):1084-1090. PMC: 10642432. DOI: 10.4254/wjh.v15.i10.1084. View

5.
Wong F . Management of ascites in cirrhosis. J Gastroenterol Hepatol. 2011; 27(1):11-20. DOI: 10.1111/j.1440-1746.2011.06925.x. View